Randomized clinical trials have long been the gold standard for drug and device approvals. Now Big Data powers “real-world evidence” that plays a growing role in medical decisions and FDA approvals.

The randomized controlled trial is a mainstay of medical research, but Banerjee was the first to apply it to the study of poverty reduction. His lessons from around the world about what works.

Experts at the University of Maryland have long been involved in developing vaccines for emerging diseases. Now they are at work on one for coronavirus.

Scientific research often goes unpublished – and what is published is often spun hard.

Researcher cautions reporters against “falsely balanced reporting” on vaccine hesitancy.

When a ‘100-year flood’ means very different things to different people.

At the famed Curie Institute in Paris, researchers are going small to understand – and develop interventions for – cancer.

Can public health officials do anything to eliminate the vast differences in health by community or income?

More than just a legal and moral issue, the use of torture is also a health issue.

Reporters often get it wrong when writing about medical and scientific research. How you can avoid doing so.

Public health leader Sir Michael Marmot details how “deaths of despair” are hurting life expectancy around the globe.

At Institute Pasteur in Paris, researchers help develop new vaccines for emerging threats.

From the cultural to the scientific and legal, the field of hate studies is growing worldwide.

The world is full of signals of potential calamities. How does the World Health Organization decide what to respond to?

Even on controversial issues, public confidence in scientists has remained steady.

What scientists believe and what the public believes have long been at odds.

People recovering from injuries used to try to limit movement to avoid pain. Now, they are being challenged to work through it.

The opioid epidemic has been fueled by a scientific mistake, a greedy industry and a tricky brain.

From malaria to emerging pathogens, center at the University of Maryland seeks to equalize health by pursuing new vaccines.

An industry researcher describes new technologies used to develop new vaccines.

From a ‘one-dimensional view of dementia,’ federal researchers are exploring new ways to understanding the disease.

A Georgetown University professor lays out what researchers have learned about Alzheimer’s and dementia.

What pollution lurks indoors? Scientists are studying the chemistry of the indoors in a first-ever collaboration of this size.

People spend 90 percent of their time indoors, so why is science focused on outdoor pollution?

How does the brain age – and is memory loss inevitable?

Despite headlines of people living to 150, a researcher says that is too optimistic.

The scientific director of the National Institute on Aging explains how – and why – people are growing older, and often doing so with their health intact.

For scientists seeking therapeutic cures for brain disorders such as Alzheimer’s, drug development starts with lab work replicating the effects of the diseases.

Helping the media and the pubic understand the real risks they face – or the real benefit of emerging clinical treatments.